Literature DB >> 7730305

Modeling of liver citric acid cycle and gluconeogenesis based on 13C mass isotopomer distribution analysis of intermediates.

C A Fernandez1, C Des Rosiers.   

Abstract

We have developed and implemented a model that can predict the positional isotopomer distribution of various hepatic metabolites labeled with [U-13C3]lactate and/or [U-13C3]pyruvate for given relative flux rates through the citric acid cycle and gluconeogenesis reactions. Our model includes (i) isotopic exchange between alpha-ketoglutarate and glutamate, (ii) a reversible isocitrate dehydrogenase reaction, (iii) an active ATP-citrate lyase, and (iv) aspartate and malate shuttles with separate cytosolic and mitochondrial pools for oxaloacetate, malate, and fumarate. A parameter estimation routine fit the mass isotopomer distribution of selected metabolites measured by gas chromatography-mass spectrometry to the model predicted distributions. We fit measured mass isotopomer distributions of phosphoenolpyruvate, citrate, alpha-ketoglutarate, glutamate, and pyruvate isolated from fasted rat livers perfused with [U-13C3]lactate + [U-13C3]pyruvate. This fitting yielded rates which we express relative to that of pyruvate carboxylase: citric acid cycle represented by the irreversible alpha-ketoglutarate dehydrogenase = 0.32; citrate synthase = 0.64; reversal of isocitrate dehydrogenase = 0.52; citrate lyase = 0.33, aspartate shuttle = 0.24, and malate shuttle = 0.44. Rates calculated for the cytosolic and mitochondrial fumarate and malate dehydrogenase reactions are subject to uncertainties as indicated by identifiability analyses. Previous forms of our model that did not include pyruvate kinase, exchange of alpha-ketoglutarate with glutamate, reversibility of isocitrate dehydrogenase, and/or ATP-citrate lyase activity were not as successful at predicting our measured values. This model offers a general tool for studying the regulation of the citric acid cycle and gluconeogenesis and can be readily modified for any 13C-labeled lactate or pyruvate substrate.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7730305     DOI: 10.1074/jbc.270.17.10037

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Production of hyperpolarized 13CO2 from [1-13C]pyruvate in perfused liver does reflect total anaplerosis but is not a reliable biomarker of glucose production.

Authors:  Karlos X Moreno; Christopher L Moore; Shawn C Burgess; A Dean Sherry; Craig R Malloy; Matthew E Merritt
Journal:  Metabolomics       Date:  2015-01-09       Impact factor: 4.290

2.  Mass spectrometry-based microassay of (2)H and (13)C plasma glucose labeling to quantify liver metabolic fluxes in vivo.

Authors:  Clinton M Hasenour; Martha L Wall; D Emerson Ridley; Curtis C Hughey; Freyja D James; David H Wasserman; Jamey D Young
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-05-19       Impact factor: 4.310

3.  Measuring deuterium enrichment of glucose hydrogen atoms by gas chromatography/mass spectrometry.

Authors:  Maciek R Antoniewicz; Joanne K Kelleher; Gregory Stephanopoulos
Journal:  Anal Chem       Date:  2011-03-17       Impact factor: 6.986

4.  Limitations of detection of anaplerosis and pyruvate cycling from metabolism of [1-(13)C] acetate.

Authors:  Shawn C Burgess; Mathew E Merritt; John G Jones; Jeffrey D Browning; A Dean Sherry; Craig R Malloy
Journal:  Nat Med       Date:  2015-02       Impact factor: 53.440

Review 5.  Cardiac anaplerosis in health and disease: food for thought.

Authors:  Christine Des Rosiers; François Labarthe; Steven G Lloyd; John C Chatham
Journal:  Cardiovasc Res       Date:  2011-03-11       Impact factor: 10.787

6.  1,25-dihydroxyvitamin D regulation of glucose metabolism in Harvey-ras transformed MCF10A human breast epithelial cells.

Authors:  Wei Zheng; Fariba Tayyari; G A Nagana Gowda; Daniel Raftery; Eric S McLamore; Jin Shi; D Marshall Porterfield; Shawn S Donkin; Brian Bequette; Dorothy Teegarden
Journal:  J Steroid Biochem Mol Biol       Date:  2013-04-22       Impact factor: 4.292

7.  tcaSIM: A Simulation Program for Optimal Design of 13C Tracer Experiments for Analysis of Metabolic Flux by NMR and Mass Spectroscopy.

Authors:  Jeffry R Alger; A Dean Sherry; Craig R Malloy
Journal:  Curr Metabolomics       Date:  2018

8.  Active pyruvate dehydrogenase and impaired gluconeogenesis in orthotopic hepatomas of rats.

Authors:  Min Hee Lee; Ralph J DeBerardinis; Xiaodong Wen; Ian R Corbin; A Dean Sherry; Craig R Malloy; Eunsook S Jin
Journal:  Metabolism       Date:  2019-10-28       Impact factor: 8.694

9.  Direct assessment of hepatic mitochondrial oxidative and anaplerotic fluxes in humans using dynamic 13C magnetic resonance spectroscopy.

Authors:  Douglas E Befroy; Rachel J Perry; Nimit Jain; Sylvie Dufour; Gary W Cline; Jeff K Trimmer; Julia Brosnan; Douglas L Rothman; Kitt Falk Petersen; Gerald I Shulman
Journal:  Nat Med       Date:  2013-12-08       Impact factor: 53.440

10.  Applications of metabolomics and proteomics to the mdx mouse model of Duchenne muscular dystrophy: lessons from downstream of the transcriptome.

Authors:  Julian L Griffin; Christine Des Rosiers
Journal:  Genome Med       Date:  2009-03-25       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.